Gpt Healthcare Stock Current Valuation
| GPTHEALTH | 138.87 0.13 0.09% |
Valuation analysis of GPT Healthcare helps investors to measure GPT Healthcare's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, GPT Healthcare's Other Cashflows From Financing Activities is quite stable compared to the past year. Other Cashflows From Investing Activities is expected to rise to about 194.3 M this year, although the value of Cash will most likely fall to about 18.5 M. Fundamental drivers impacting GPT Healthcare's valuation include:
Price Book 4.8052 | Enterprise Value 11.1 B | Enterprise Value Ebitda 11.8343 | Price Sales 2.7717 | Trailing PE 32.1876 |
Overvalued
Today
Please note that GPT Healthcare's price fluctuation is very steady at this time. Calculation of the real value of GPT Healthcare is based on 3 months time horizon. Increasing GPT Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the GPT stock is determined by what a typical buyer is willing to pay for full or partial control of GPT Healthcare. Since GPT Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of GPT Stock. However, GPT Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 138.87 | Real 124.49 | Hype 138.87 | Naive 143.25 |
The intrinsic value of GPT Healthcare's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence GPT Healthcare's stock price.
Estimating the potential upside or downside of GPT Healthcare helps investors to forecast how GPT stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of GPT Healthcare more accurately as focusing exclusively on GPT Healthcare's fundamentals will not take into account other important factors: GPT Healthcare Company Current Valuation Analysis
GPT Healthcare's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current GPT Healthcare Current Valuation | 11.09 B |
Most of GPT Healthcare's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GPT Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, GPT Healthcare has a Current Valuation of 11.09 B. This is 22.76% lower than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The current valuation for all India stocks is 33.27% higher than that of the company.
GPT Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GPT Healthcare's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GPT Healthcare could also be used in its relative valuation, which is a method of valuing GPT Healthcare by comparing valuation metrics of similar companies.GPT Healthcare is currently under evaluation in current valuation category among its peers.
GPT Fundamentals
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 11.09 B | ||||
| Shares Outstanding | 82.05 M | ||||
| Shares Owned By Insiders | 67.78 % | ||||
| Shares Owned By Institutions | 14.62 % | ||||
| Price To Book | 4.81 X | ||||
| Price To Sales | 2.77 X | ||||
| Revenue | 4 B | ||||
| EBITDA | 925.2 M | ||||
| Net Income | 680.43 M | ||||
| Total Debt | 305.43 M | ||||
| Book Value Per Share | 26.63 X | ||||
| Cash Flow From Operations | 688 M | ||||
| Earnings Per Share | 5.81 X | ||||
| Number Of Employees | 1.89 K | ||||
| Market Capitalization | 15.35 B | ||||
| Total Asset | 3.46 B | ||||
| Retained Earnings | 859.23 M | ||||
| Annual Yield | 0.02 % | ||||
| Net Asset | 3.46 B | ||||
| Last Dividend Paid | 1.5 |
About GPT Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GPT Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GPT Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GPT Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in GPT Stock
GPT Healthcare financial ratios help investors to determine whether GPT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GPT with respect to the benefits of owning GPT Healthcare security.